AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes... Read more
AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes... Read more
CEO
Add
News
Jan 12, 2016
BioPortfolio
Abvitro: Juno Therapeutics acquires AbVitro adding nextgen single cell sequencing capabilities
Jan 11, 2016
Genetic Engineering & Biotechnology News
Abvitro: Juno's AbVitro Acquisition Adds Sequencing to Repertoire
Jan 10, 2016
The Seattle Times - Business & Tech
Abvitro: Juno buys Boston biotech AbVitro for $120 million
Jan 10, 2016
Bidness Etc
Abvitro: Juno Therapeutics Purchases AbVitro For $125 Million
Aug 20, 2015
BIOSPACE
Abvitro: AbVitro To Provide Academic Institutions Access To Its AbPair Technology Through A Grant Challenge Program
Aug 20, 2015
PR NEWSWIRE
Press Release: Abvitro : AbVitro to Provide Academic Institutions Access to its AbPair Technology Through a Grant Challenge Program
Apr 16, 2015
PR NEWSWIRE
Press Release: Abvitro : AbVitro Inc. to Present at the American Association for Cancer Research Annual Meeting
Apr 15, 2015
BIOSPACE
Abvitro: AbVitro To Present At The American Association for Cancer Research Annual Meeting
Nov 04, 2014
BIOSPACE
Abvitro: <b>AbVitro Inc.</b> Appoints <b>Samuel Broder, M.D.</b>, To Its Board Of Directors And Scientific Advisory Board
Oct 23, 2014
BIOSPACE
Abvitro: <b>AbVitro Inc.</b> Appoints <b>Jeffrey M. Ostrove, Ph.D.</b> As Chief Executive Officer
Abvitro Competitors
1
2
3
4
5
6
7
8
9